FOLH1 and renal cell carcinoma: In 2018, an immunochemistry study of 227 RCC patients with a median follow-up of more than 10.0 years showed that the intensity of positive versus negative prostate-specific membrane antigen protein expression was significantly associated with overall survival [54].